CPRX vs WAB · P/E 18, rev $491.7M vs P/E 38, rev $3.18B
Catalyst Pharmaceuticals Inc (CPRX) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported WAB revenue for 2026-06-30 was $3.18B. Net income was $395.0M. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the CPRX and WAB stock pages for the full models.
Not investment advice.